This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Colorectal Neoplasia Is The Presence Of Abnormal Growths In The Colon And Rectum That Can Be Cancerous Or Noncancerous. It Is One Of The Most Common Forms Of Cancer, With Over 140,000 Cases Diagnosed In The United States Each Year. Colorectal Neoplasia Is Caused By A Variety Of Factors, Including Genetics, Environmental Exposures, And Lifestyle Habits. For Example, Those With A Family History Of Colorectal Cancer Are At An Increased Risk For Developing The Disease. Additionally, Certain Lifestyle Habits, Such As Smoking, Alcohol Use, And Diets High In Red And Processed Meats Can Increase The Risk Of Developing Colorectal Cancer. Screening For Colorectal Neoplasia Is An Important Part Of Preventive Health Care. Screening Can Detect Potential Precancerous Lesions Before They Become Cancerous, Allowing For Early Treatment And Improved Outcomes. Screening Also Helps To Identify Those At High Risk For Colorectal Cancer, Allowing For More Intensive Monitoring And Treatment. Common Screening Tests Include Colonoscopy, Flexible Sigmoidoscopy, And Fecal Occult Blood Tests. When Detected Early, Colorectal Neoplasia Is Highly Treatable. Treatments Vary Depending On The Type And Stage Of The Disease. Surgery Is Often Required To Remove The Affected Area And Can Be Combined With Chemotherapy Or Radiation Therapy For More Advanced Cases. Other Treatments, Such As Lifestyle Changes And Medications, Can Also Be Used To Reduce The Risk Of Recurrence. Colorectal Neoplasia Is A Serious Disease, But It Is Highly Treatable When Detected Early. Regular Screening Tests Are Essential For Early Detection, And Those At High Risk Should Talk To Their Doctor About Their Screening Options. With The Right Treatment, Patients Can Have A Good Chance Of A Successful Outcome.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States